• 1. Always a matter of interpretation: inferring student knowledge and understanding from research data
  Chem. Educ. Res. Pract., 2017,18, 7-12
• 2. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 3. Achieving molecular stability of racemic 4-O-benzyl-myo-inositol-1,3,5-orthoformate through crystal formation?
  Richa Sardessai,Shobhana Krishnaswamy,Mysore S. Shashidhar CrystEngComm, 2012,14, 8010-8016
• 4. Ambient electrochemical NH3 synthesis from N2 and water enabled by ZrO2 nanoparticles?
  Tong Xu,Dongwei Ma,Chengbo Li,Qian Liu,Siyu Lu,Abdullah M. Asiri,Chun Yang,Xuping Sun Chem. Commun., 2020,56, 3673-3676
• 5. An arsenic trioxide nanoparticle prodrug (ATONP) potentiates a therapeutic effect on an aggressive hepatocellular carcinoma model via enhancement of intratumoral arsenic accumulation and disturbance of the tumor microenvironment?
  Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Hydroquinolones
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Quinolones and derivatives Hydroquinolones

Professional Introduction to 7-Bromo-4-hydroxy-2-methylquinoline (CAS No. 56716-92-8)

7-Bromo-4-hydroxy-2-methylquinoline, with the chemical formula C₁₀H₉BBrNO, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical and chemical research. This compound belongs to the quinoline family, which is well-known for its broad spectrum of biological activities and applications in medicinal chemistry. The presence of both bromine and hydroxyl substituents in its structure enhances its reactivity, making it a valuable intermediate in the synthesis of various pharmacologically active molecules.

The CAS number 56716-92-8 uniquely identifies this compound and distinguishes it from other quinoline derivatives. This numerical identifier is crucial for researchers and regulatory bodies to ensure accurate documentation, classification, and handling of the substance. The structural features of 7-Bromo-4-hydroxy-2-methylquinoline make it a versatile building block for the development of new drugs targeting diverse therapeutic areas.

In recent years, there has been a surge in research focused on quinoline derivatives due to their potential as antimicrobial, antimalarial, anticancer, and anti-inflammatory agents. The bromine atom in 7-Bromo-4-hydroxy-2-methylquinoline serves as a handle for further functionalization via cross-coupling reactions, such as Suzuki-Miyaura or Buchwald-Hartwig couplings, which are pivotal in constructing complex molecular architectures. These reactions allow for the introduction of additional functional groups, enabling the synthesis of novel compounds with enhanced biological activity.

The hydroxyl group at the 4-position adds another layer of reactivity, facilitating nucleophilic substitution reactions and allowing for the formation of ether or ester linkages. These modifications can significantly influence the pharmacokinetic properties of derived compounds, including their solubility, bioavailability, and metabolic stability. The methyl group at the 2-position contributes to the overall stability of the quinoline core while also influencing electronic distribution, which can affect binding interactions with biological targets.

One of the most compelling aspects of 7-Bromo-4-hydroxy-2-methylquinoline is its role in the development of next-generation therapeutics. For instance, recent studies have demonstrated its utility in generating derivatives with potent antitumor properties. Researchers have leveraged its structural framework to design molecules that selectively inhibit kinases involved in cancer cell proliferation. The bromine substituent has been particularly useful in these efforts, enabling precise modifications that enhance target specificity while minimizing off-target effects.

Moreover, the hydroxyl group has been exploited to create prodrugs or analogs with improved pharmacological profiles. By incorporating this moiety, scientists have been able to develop compounds that exhibit sustained release or enhanced penetration across biological barriers. Such advancements are critical for improving therapeutic outcomes and patient compliance.

The synthesis of 7-Bromo-4-hydroxy-2-methylquinoline typically involves multi-step organic transformations starting from readily available precursors. Common synthetic routes include bromination of quinoline derivatives followed by selective hydroxylation and methylation. These processes highlight the compound's importance as a synthetic intermediate and underscore its accessibility for further medicinal chemistry endeavors.

In terms of applications beyond pharmaceuticals, 7-Bromo-4-hydroxy-2-methylquinoline has shown promise in materials science. Its ability to undergo various functionalization reactions makes it a valuable precursor for designing organic semiconductors and luminescent materials. These applications are particularly relevant in the development of advanced electronic devices and optoelectronic materials, where precise molecular engineering is essential.

The growing interest in green chemistry has also influenced research on this compound. Efforts are underway to develop more sustainable synthetic methodologies that minimize waste and reduce energy consumption. Such initiatives align with global efforts to promote environmentally responsible chemical practices while maintaining high standards of efficiency and yield.

Future directions in the study of 7-Bromo-4-hydroxy-2-methylquinoline include exploring its potential as an intermediate in drug discovery programs targeting emerging infectious diseases. The rise of drug-resistant pathogens necessitates innovative approaches to develop new antibiotics and antivirals. Quinoline derivatives continue to be a cornerstone in this endeavor, offering a rich scaffold for structural diversification and optimization.

Additionally, computational modeling and high-throughput screening techniques are being increasingly employed to accelerate the discovery process. These tools enable researchers to predict the biological activity of derived compounds before conducting costly wet-lab experiments. By integrating such methodologies with traditional synthetic approaches, scientists can more efficiently identify promising candidates for further development.

In conclusion, 7-Bromo-4-hydroxy-2-methylquinoline (CAS No. 56716-92-8) is a multifaceted compound with significant potential in pharmaceuticals and materials science. Its unique structural features make it an invaluable intermediate for synthesizing biologically active molecules with diverse therapeutic applications. As research continues to evolve, this compound will undoubtedly play a crucial role in addressing some of today's most pressing scientific challenges.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)